Research programme: stem cell-based therapeutics - Allele Biotechnology and PharmaceuticalsAlternative Names: iPSC- Allele Biotechnology & Pharmaceuticals; stem cell-based therapeutics - Allele Biotechnology and Pharmaceuticals
Latest Information Update: 17 Jan 2017
At a glance
- Originator Allele Biotechnology and Pharmaceuticals
- Class Stem cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Diabetes mellitus; Spinal cord injuries